BioXcel Therapeutics, Inc.
BTAIQ- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001720893
No open-market purchases or sales by BioXcel Therapeutics, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $8.69M in total; Oaktree Capital is the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in BioXcel Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 97
- +13 vs. Q4 2022
- Shares held
- 17.4M
- +3.97M (+29.5%) vs. Q4 2022
- Total value
- $325.0M
- +$36.1M (+12.5%) vs. Q4 2022
- New holders
- 23
- 30 more added
- Sold out
- 10
- 28 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BTAIQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 47 | $8.69M |
| Q1 2026 | 40 | $7.28M |
| Q4 2025 | 41 | $5.66M |
| Q3 2025 | 35 | $6.05M |
| Q2 2025 | 35 | $1.09M |
| Q1 2025 | 31 | $769.7K |
| Q4 2024 | 49 | $3.22M |
| Q3 2024 | 50 | $1.89M |
| Q2 2024 | 74 | $12.5M |
| Q1 2024 | 74 | $26.1M |
| Q4 2023 | 73 | $27.6M |
| Q3 2023 | 86 | $25.8M |
| Q2 2023 | 88 | $117.8M |
| Q1 2023 | 97 | $325.0M |
| Q4 2022 | 84 | $288.9M |
| Q3 2022 | 85 | $140.3M |
| Q2 2022 | 94 | $167.4M |
| Q1 2022 | 96 | $273.9M |
| Q4 2021 | 93 | $283.1M |
| Q3 2021 | 104 | $388.3M |
| Q2 2021 | 109 | $378.6M |
| Q1 2021 | 118 | $475.2M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding BioXcel Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −16,576−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −16,270−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −13,706−100.0% | Sold out |
| Harvest Investment Services, LLC | 0 | $0 | 0.00% | −10,171−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −900−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −867−100.0% | Sold out |
| Worth Asset Management, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |